Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease

Bibliographic Details
Title: Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease
Authors: Meriem Belheouane, Britt M. Hermes, Nina Van Beek, Sandrine Benoit, Philippe Bernard, Kossara Drenovska, Sascha Gerdes, Regine Gläser, Matthias Goebeler, Claudia Günther, Anabelle von Georg, Christoph M. Hammers, Maike M. Holtsche, Bernhard Homey, Orsolya N. Horváth, Franziska Hübner, Beke Linnemann, Pascal Joly, Dalma Márton, Aikaterini Patsatsi, Claudia Pföhler, Miklós Sárdy, Laura Huilaja, Snejina Vassileva, Detlef Zillikens, Saleh Ibrahim, Christian D. Sadik, Enno Schmidt, John F. Baines
Source: Journal of Advanced Research, Vol 44, Iss , Pp 71-79 (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Medicine (General)
LCC:Science (General)
Subject Terms: Autoimmune blistering disease, Bullous pemphigoid, Skin microbiota, 16s rRNA gene sequencing, Risk factor, Medicine (General), R5-920, Science (General), Q1-390
More Details: Introduction: Bullous pemphigoid (BP) is the most common autoimmune blistering disease. It predominately afflicts the elderly and is significantly associated with increased mortality. The observation of age-dependent changes in the skin microbiota as well as its involvement in other inflammatory skin disorders suggests that skin microbiota may play a role in the emergence of BP blistering. We hypothesize that changes in microbial diversity associated with BP might occur before the emergence of disease lesions, and thus could represent an early indicator of blistering risk. Objectives: The present study aims to investigate potential relationships between skin microbiota and BP and elaborate on important changes in microbial diversity associated with blistering in BP. Methods: The study consisted of an extensive sampling effort of the skin microbiota in patients with BP and age- and sex-matched controls to analyze whether intra-individual, body site, and/or geographical variation correlate with changes in skin microbial composition in BP and/or blistering status. Results: We find significant differences in the skin microbiota of patients with BP compared to that of controls, and moreover that disease status rather than skin biogeography (body site) governs skin microbiota composition in patients with BP. Our data reveal a discernible transition between normal skin and the skin surrounding BP lesions, which is characterized by a loss of protective microbiota and an increase in sequences matching Staphylococcus aureus, a known inflammation-promoting species. Notably, Staphylococcus aureus is ubiquitously associated with BP disease status, regardless of the presence of blisters. Conclusion: The present study suggests Staphylococcus aureus may be a key taxon associated with BP disease status. Importantly, we however find contrasting patterns in the relative abundances of Staphylococcus hominis and Staphylococcus aureus reliably discriminate between patients with BP and matched controls. This may serve as valuable information for assessing blistering risk and treatment outcomes in a clinical setting.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2090-1232
Relation: http://www.sciencedirect.com/science/article/pii/S2090123222000819; https://doaj.org/toc/2090-1232
DOI: 10.1016/j.jare.2022.03.019
Access URL: https://doaj.org/article/d9ddef24c8b04f35b5b9b43f2701694a
Accession Number: edsdoj.9ddef24c8b04f35b5b9b43f2701694a
Database: Directory of Open Access Journals
More Details
ISSN:20901232
DOI:10.1016/j.jare.2022.03.019
Published in:Journal of Advanced Research
Language:English